In acute coronavirus disease 19 (COVID‐19) patients, effective clinical risk stratification has
important implications on treatment and therapeutic resource distribution. This article …

Coronavirus disease-19 (COVID-19) emerged late December 2019 in the city of Wuhan,
China and has since spread rapidly all over the world causing a global pandemic. While the …

Background: Biomarkers were correlated with mortality in critically ill COVID-19 patients. No
prediction tools exist for noncritically ill COVID-19 patients. We aimed to compare the …

Abstract Background During COVID‐19 outbreak, Italy was the first country in Europe to be
heavily affected with an intensive care unit mortality of 26%. In order to reduce this …

Aims To evaluate the acute and chronic patterns of myocardial injury among patients with
coronavirus disease-2019 (COVID-19), and their mid-term outcomes. Methods and results …

Infection with the novel severe acute respiratory coronavirus-2 (SARS-CoV2) results in
COVID-19, a disease primarily affecting the respiratory system to provoke a spectrum of …

Introduction Assessment of inpatient mortality risk in COVID-19 patients is important for
guiding clinical decision-making. High sensitivity cardiac troponin T (hs-cTnT) is a biomarker …

Type I interferon (IFN) is critical in our defense against viral infections. Increased type I IFN
pathway activation is a genetic risk factor for systemic lupus erythematosus (SLE), and a …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection caused
worldwide health problems, and coronavirus disease 2019 (COVID-19) was declared a …

Background: Galectin-3 has been shown to play a key pathophysiological role in pulmonary
associated inflamma-tory response and lung fibrosis in COVID-19 and is a mediator for viral …